Disclosure Panels Details Page
Ovarian Cancer Panel - Disclosures as of 07/13/2012
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Ronald Alvarez MD | Morphotek Inc. Pfizer Inc. |
Astellas Pharma US, Inc. Genentech, Inc. |
None | None | ✔ |
| Deborah Armstrong MD | Astellas Pharma US, Inc. Genentech, Inc. MedImmune Inc. Morphotek Inc. |
Genentech, Inc. Morphotek Inc. |
None | None | ✔ |
| Robert Burger MD, FACOG, FACS | Genentech, Inc. | Champions Biotech Clovis Oncology Endocyte GSK Nektar sanofi-aventis U.S. |
None | None | - |
| Lee-May Chen MD | AstraZeneca Pharmaceuticals LP | None | None | None | - |
| Larry Copeland MD | Eli Lilly and Company Genentech, Inc. |
Boehringer Ingelheim GmbH Eisai Inc. Genentech, Inc. |
None | None | - |
| Marta Ann Crispens MD | Morphotek Inc. Spirogen |
None | None | None | ✔ |
| Mary Dwyer MS | None | None | None | None | ✔ |
| Lauren Gallagher | None | None | None | None | ✔ |
| David Gershenson MD | AstraZeneca Pharmaceuticals LP Genentech, Inc. National Cancer Institute |
None | None | Elsevier|Informa|Johnson & Johnson|National Cancer Institute|Pfizer Inc.|Up to Date | - |
| Heidi Gray MD | Abbott Laboratories Prima Biomed |
Prima Biomed | None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Ardeshir Hakam MD | None | None | None | None | ✔ |
| Laura Havrilesky MD | BD TriPath Oncology | BD-TriPath Oncology | None | None | ✔ |
| Miranda Hughes PhD | None | None | None | None | ✔ |
| Carolyn Johnston MD | None | None | None | american cancer society-great lakes division|michigan cancer consortium | - |
| Shashikant Lele MD | None | None | None | None | ✔ |
| Lainie Martin MD | None | None | None | None | - |
| Ursula Matulonis MD | AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Eli Lilly and Company Genentech, Inc. Merck & Co., Inc. |
Clovis Pathway Therapeutics |
None | None | ✔ |
| Joan McClure MS | None | None | None | None | ✔ |
| Robert Morgan MD, FACP | NIH-CTEP | None | None | None | ✔ |
| David O'Malley MD | Genentech, Inc. | Genentech, Inc. Johnson & Johnson |
None | None | - |
| Richard Penson MD, MRCP | Amgen Inc. AstraZeneca Pharmaceuticals LP Eisai Inc. Eli Lilly and Company Endocyte Inc. Genentech, Inc. ImClone Systems Incorporated |
AstraZeneca Pharmaceuticals LP BioMarin Clovis Oncology Genentech, Inc. Lifecore Biomedical |
None | None | - |
| Matthew Powell MD | Bristol Myers Squibb Eisai Inc. |
Merck & Co., Inc. | None | None | ✔ |
| Steven Remmenga MD | None | None | None | None | - |
| Paul Sabbatini MD | Prim Biomed | None | None | None | - |
| Joseph Santoso MD | None | lab cor vermillion |
None | None | - |
| Julian Schink | None | Genentech, Inc. | None | None | ✔ |
| Nelson Teng MD, PhD | NA | NA | NA | NA | ✔ |
| Theresa Werner MD | None | None | None | None | ✔ |